ArticleJournal of medical virology2023

A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infection.

Anna M Hassebroek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.